199 related articles for article (PubMed ID: 32630661)
1. EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer.
van den Brand D; van Lith SAM; de Jong JM; Gorris MAJ; Palacio-Castañeda V; Couwenbergh ST; Goldman MRG; Ebisch I; Massuger LF; Leenders WPJ; Brock R; Verdurmen WPR
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630661
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Nucl Med Mol Imaging; 2023 Aug; ():. PubMed ID: 37642704
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1.
Vorobyeva A; Konovalova E; Xu T; Schulga A; Altai M; Garousi J; Rinne SS; Orlova A; Tolmachev V; Deyev S
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392820
[TBL] [Abstract][Full Text] [Related]
4. Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1.
Deyev SM; Vorobyeva A; Schulga A; Abouzayed A; Günther T; Garousi J; Konovalova E; Ding H; Gräslund T; Orlova A; Tolmachev V
Int J Biol Macromol; 2020 Feb; 145():216-225. PubMed ID: 31863835
[TBL] [Abstract][Full Text] [Related]
5. DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency.
Stefan N; Martin-Killias P; Wyss-Stoeckle S; Honegger A; Zangemeister-Wittke U; Plückthun A
J Mol Biol; 2011 Nov; 413(4):826-43. PubMed ID: 21963989
[TBL] [Abstract][Full Text] [Related]
6. Assessing the use of tumor-specific DARPin-toxin fusion proteins for ex vivo purging of cancer metastases from human ovarian cortex before autotransplantation.
Eijkenboom L; Palacio-Castañeda V; Groenman F; Braat D; Beerendonk C; Brock R; Verdurmen W; Peek R
F S Sci; 2021 Nov; 2(4):330-344. PubMed ID: 35559858
[TBL] [Abstract][Full Text] [Related]
7. Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model.
Xu T; Vorobyeva A; Schulga A; Konovalova E; Vorontsova O; Ding H; Gräslund T; Tashireva LA; Orlova A; Tolmachev V; Deyev SM
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439094
[TBL] [Abstract][Full Text] [Related]
8. Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with
Tolmachev V; Bodenko V; Orlova A; Schulga A; Deyev SM; Vorobyeva A
Oncol Lett; 2023 Jan; 25(1):12. PubMed ID: 36478911
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.
Xu T; Schulga A; Konovalova E; Rinne SS; Zhang H; Vorontsova O; Orlova A; Deyev SM; Tolmachev V; Vorobyeva A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769161
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
[TBL] [Abstract][Full Text] [Related]
11. Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2.
Lv YF; Zhang H; Cui Z; Ma CJ; Li YL; Lu H; Wu HY; Yang JL; Cao CY; Sun WZ; Huang XF
BMC Cancer; 2023 Dec; 23(1):1220. PubMed ID: 38082377
[TBL] [Abstract][Full Text] [Related]
12. Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1.
Deyev SM; Xu T; Liu Y; Schulga A; Konovalova E; Garousi J; Rinne SS; Larkina M; Ding H; Gräslund T; Orlova A; Tolmachev V; Vorobyeva A
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298801
[TBL] [Abstract][Full Text] [Related]
13. DARPin Ec1-LMWP protein scaffold in targeted delivery of siRNA molecules through EpCAM cancer stem cell marker.
Babaee N; Talebkhan Garoosi Y; Karimipoor M; Davami F; Bayat E; Safarpour H; Mahboudi F; Barkhordari F
Mol Biol Rep; 2020 Oct; 47(10):7323-7331. PubMed ID: 32979162
[TBL] [Abstract][Full Text] [Related]
14. A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity.
Martin-Killias P; Stefan N; Rothschild S; Plückthun A; Zangemeister-Wittke U
Clin Cancer Res; 2011 Jan; 17(1):100-10. PubMed ID: 21075824
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic Construction of DARPin-Based Targeted Delivery Systems Using Protein Farnesyltransferase and a Capture and Release Strategy.
Zhang Y; Wang Y; Uslu S; Venkatachalapathy S; Rashidian M; Schaefer JV; Plückthun A; Distefano MD
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232839
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells.
Xu T; Liu Y; Schulga A; Konovalova E; Deyev SM; Tolmachev V; Vorobyeva A
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35315504
[TBL] [Abstract][Full Text] [Related]
17. Orthogonal assembly of a designed ankyrin repeat protein-cytotoxin conjugate with a clickable serum albumin module for half-life extension.
Simon M; Frey R; Zangemeister-Wittke U; Plückthun A
Bioconjug Chem; 2013 Nov; 24(11):1955-66. PubMed ID: 24168270
[TBL] [Abstract][Full Text] [Related]
18. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
English DP; Bellone S; Schwab CL; Roque DM; Lopez S; Bortolomai I; Cocco E; Bonazzoli E; Chatterjee S; Ratner E; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Santin AD
Cancer; 2015 Feb; 121(3):403-12. PubMed ID: 25251053
[TBL] [Abstract][Full Text] [Related]
19. A Hybrid In Silico and Tumor-on-a-Chip Approach to Model Targeted Protein Behavior in 3D Microenvironments.
Palacio-Castañeda V; Dumas S; Albrecht P; Wijgers TJ; Descroix S; Verdurmen WPR
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070171
[TBL] [Abstract][Full Text] [Related]
20. Facile double-functionalization of designed ankyrin repeat proteins using click and thiol chemistries.
Simon M; Zangemeister-Wittke U; Plückthun A
Bioconjug Chem; 2012 Feb; 23(2):279-86. PubMed ID: 22188139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]